Skip to main content
Premium Trial:

Request an Annual Quote

Knome, Personal Genomics Ink Sales, Scientific Agreement

NEW YORK (GenomeWeb News) – Knome and Personal Genomics today announced an exclusive sales agreement and a scientific partnership covering Knome's knoSys platform.

Personal Genomics, based in Verona, Italy, becomes Knome's first international distributor, Personal Genomics CEO Marco Dotto said in a statement. Additionally, his firm will continue developing tools, content, and applications for knoSys, which is used for managing and interpreting sequencing data. The platform combines analytical and workflow software with grid computers.

There are two knoSys models, the knoSys 100 for high-throughput genomics, and the knoSys 25 for labs working on targeted panels and a moderate number of exomes and genomes, said Cambridge, Mass.-based Knome, which raised $13 million in January to grow its business.

Financial and other terms of the deal were not disclosed.